Elucidating the mechanism of baicalein-rich fraction from oroxylum indicum leaves in cervical cancer cell lines
Loading...
Date
2020-07
Authors
Wahab, Nurul Hidayah
Journal Title
Journal ISSN
Volume Title
Publisher
Pusat Pengajian Sains Perubatan, Universiti Sains Malaysia
Abstract
modulation action on the expression of interleukin (IL)-6 and IL-12 by conducting an
enzyme-linked immunosorbent assay (ELISA). As a result, BRF with 75% of
baicalein was found to be the most potent compound compared to cisplatin (anticancer
drug) and MCE based on the IC50 values obtained from both cells. After 24
hours treatment period, Western blot analysis showed that BRF-treated SiHa and
HeLa cells downregulated the expression of E6 and E7 and restored the induction of
apoptosis process through the up-regulation of p53 and pRb in treated cells. In terms
of mitochondrial-mediated apoptosis pathway, BRF has positively enhanced the
activation pathway by downregulating Bcl-2 anti-apoptotic protein and upregulating
the required key components such as Bax, caspase-9 as well as caspase-3. In regard
to MAPK signalling cascade, the pro-apoptotic activities of BRF in SiHa and HeLa
cells have been found to be MAPK-dependent as all its subfamilies involved in BRFinduced
apoptosis but in different approach. BRF induced apoptosis in cervical
cancer cells predominantly through ERK inhibition and JNK activation. Besides,
BRF induced Bax activation by ERK/p38 dependent pathway and suppressed Bcl-2
expression through inhibition of ERK and activation of p38. Meanwhile for HeLa
cells, activation of ERK/JNK/p38 pathways are required for Bax activation and
inhibition of both ERK/p38 signalling promoted Bcl-2 downregulation in BRFtreated
HeLa cells. Apoptosis induction by BRF also enhanced through IL-6
downregulation and IL-12 upregulation. Thus, these presented findings have proved
the ability of BRF fractionated from O. indicum’s leaves to be exploited as a
potential plant-based anti-cancer candidate for cervical cancer treatment.
Description
Keywords
cancer